Neurocognitive sequelae following seronegative anti-NMDA receptor encephalitis with ovarian teratoma in a pediatric patient: A six-year follow-up case report
Felipe Dalvi-Garcia, Iolanda de Salles Fonseca Carvalho, Julia Valeriano de Almeida, Roozemeria Pereira Costa, Ligia Caldeira da Silva, Julia Nunes Perez Fandiño · 2026
Read Neurocognitive sequelae following seronegative anti-NMDA receptor encephalitis with ovarian teratoma in a pediatric patient: A six-year follow-up case report by Felipe Dalvi-Garcia, Iolanda de Salles Fonseca Carvalho, Julia Valeriano de Almeida, Roozemeria Pereira Costa, Ligia Caldeira da Silva, Julia Nunes Perez Fandiño (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13628690.txt.
Description
Felipe Dalvi-Garcia and co-authors report six years of follow-up for a child with autoimmune encephalitis. Their 2026 case report describes a girl, adopted, who fell ill at age eleven with fast mental decline, seizures, and abnormal movements. An ovarian teratoma was found and removed during her care.
Tests for the hallmark antibody came back negative, though samples were drawn late and after treatment had begun. Her course, brain wave records, and response to immune therapy still supported a probable diagnosis. She received steroids and intravenous immunoglobulin. Six years later, testing showed strong verbal skills but clear weakness in planning, attention, processing speed, and verbal memory. She also met criteria for autism spectrum disorder.
Catalog record
| CREATOR | Felipe Dalvi-Garcia, Iolanda de Salles Fonseca Carvalho, Julia Valeriano de Almeida, Roozemeria Pereira Costa, Ligia Caldeira da Silva, Julia Nunes Perez Fandiño |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 36 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |